RBC Capital Markets reiterated their positive stance on Alnylam Pharmaceuticals (NASDAQ:ALNY), maintaining an Outperform rating and a price target of $300.00. According to InvestingPro data, analyst ...

RBC Capital analyst Gerard Cassidy maintained a Hold rating on Goldman Sachs Group (GS – Research ... Investment Banking, Global Markets, Asset Management, and Consumer & Wealth Management.

Wall Street investment bank Goldman Sachs is a man down in its small-cap equity research team. Street Talk understands analyst Chris Gawler left the building in the weeks after Goldman posted its ...

Goldman Sachs cancelled a four-year-old policy to only take public companies that had two diverse board members, a ...

Keefe, Bruyette & Woods analyst David Konrad reiterated an Outperform rating on the shares of Goldman Sachs Group Inc ... those looking to invest in capital markets, per the analyst.

Goldman Sachs would consider acquisitions in asset and wealth management, but would be highly selective about any deal, CEO ...

Aaron Lamshed moved up to head of ECM for Goldman Sachs in Australia and New Zealand in 2023. Street Talk understands the Wall Street firm’s head of equity capital markets and head of ...

Citi (C), JPMorgan Chase (JPM), Goldman Sachs (GS), and Wells Fargo (WFC) report on Wednesday, while Bank of America (BAC) and Morgan Stanley (MS) release results on Thursday. RBC Capital markets ...

Goldman Sachs (GS) plans to combine three units in its global banking and markets division that work ... be unveiled on Monday and be called the Capital Solutions Group, will include the financial ...

Goldman Sachs exceeds revenue expectations in trading ... it is still considered an attractive option for those looking to invest in capital markets, per the analyst. Due to robust revenues ...